|
Volumn 342, Issue 6160, 2013, Pages 809-811
|
Potential of the synthetic lethality principle
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
EPIDERMAL GROWTH FACTOR;
MYC PROTEIN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PROTEIN P53;
RAS PROTEIN;
RETINOBLASTOMA PROTEIN;
RETINOBLASTOMA PROTEIN 1;
UNCLASSIFIED DRUG;
TUMOR SUPPRESSOR PROTEIN;
CANCER;
DISEASE TREATMENT;
CAENORHABDITIS ELEGANS;
CARCINOGENESIS;
DNA REPAIR;
DROSOPHILA MELANOGASTER;
FEEDBACK SYSTEM;
GENE MUTATION;
LETHALITY;
NEOPLASM;
NONHUMAN;
PRIORITY JOURNAL;
RNA INTERFERENCE;
SACCHAROMYCES CEREVISIAE;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
SYNTHETIC LETHALITY;
ANIMAL;
GENE TARGETING;
GENE THERAPY;
GENETICS;
HUMAN;
IMMUNOTHERAPY;
LETHAL GENE;
MODIFIER GENE;
MOLECULARLY TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PROCEDURES;
ARTICLE;
METHODOLOGY;
ANIMALS;
DROSOPHILA MELANOGASTER;
GENE TARGETING;
GENES, LETHAL;
GENES, MODIFIER;
GENETIC THERAPY;
HUMANS;
IMMUNOTHERAPY;
MOLECULAR TARGETED THERAPY;
MUTATION;
NEOPLASMS;
SACCHAROMYCES CEREVISIAE;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 84887662629
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1244669 Document Type: Short Survey |
Times cited : (58)
|
References (14)
|